BR0215013A - Biomassa particulada de embrião aviário para a produção de antìgenos de vìrus - Google Patents

Biomassa particulada de embrião aviário para a produção de antìgenos de vìrus

Info

Publication number
BR0215013A
BR0215013A BR0215013-1A BR0215013A BR0215013A BR 0215013 A BR0215013 A BR 0215013A BR 0215013 A BR0215013 A BR 0215013A BR 0215013 A BR0215013 A BR 0215013A
Authority
BR
Brazil
Prior art keywords
virus antigen
antigen production
avian embryo
particulate biomass
biomass
Prior art date
Application number
BR0215013-1A
Other languages
English (en)
Inventor
David Lou Wederquist
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BR0215013A publication Critical patent/BR0215013A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"BIOMASSA PARTICULADA DE EMBRIãO AVIáRIO PARA A PRODUçãO DE ANTìGENOS DE VìRUS". A presente invenção refere-se a uma biomassa que compreende partículas embrionárias aviárias tendo um tamanho de partícula de cerca de 0,5 mm a 10,0 mm e seu uso em um método para a produção de antígenos de vírus. Também fornecido um método para a preparação de uma vacina útil para amenização ou prevenção de doença viral.
BR0215013-1A 2001-12-21 2002-12-18 Biomassa particulada de embrião aviário para a produção de antìgenos de vìrus BR0215013A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34333901P 2001-12-21 2001-12-21
PCT/US2002/040567 WO2003055988A1 (en) 2001-12-21 2002-12-18 An avian embryo particulate biomass for the production of virus antigens

Publications (1)

Publication Number Publication Date
BR0215013A true BR0215013A (pt) 2004-11-09

Family

ID=23345706

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215013-1A BR0215013A (pt) 2001-12-21 2002-12-18 Biomassa particulada de embrião aviário para a produção de antìgenos de vìrus

Country Status (18)

Country Link
US (3) US20040023358A1 (pt)
EP (2) EP1458851A1 (pt)
JP (1) JP2005514018A (pt)
KR (1) KR20040070250A (pt)
CN (1) CN100408675C (pt)
AR (1) AR037908A1 (pt)
AU (1) AU2002360659B2 (pt)
BR (1) BR0215013A (pt)
CA (1) CA2471131A1 (pt)
CO (1) CO5590972A2 (pt)
HR (1) HRP20040641A2 (pt)
HU (1) HU225995B1 (pt)
MX (1) MXPA04005888A (pt)
NZ (1) NZ534070A (pt)
PL (1) PL371381A1 (pt)
RS (1) RS55404A (pt)
TW (1) TWI267553B (pt)
WO (1) WO2003055988A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8237946B2 (en) * 2004-10-08 2012-08-07 Sharp Laboratories Of America, Inc. Methods and systems for imaging device accounting server redundancy
US20140255447A1 (en) * 2013-03-05 2014-09-11 Biomune Company Production of avian embryo cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH638985A5 (de) * 1979-04-10 1983-10-31 Schweiz Serum & Impfinst Verfahren zur herstellung eines tollwutimpfstoffes und danach erhaltener impfstoff.
AT393277B (de) * 1990-01-04 1991-09-25 Immuno Ag Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen
EP0772453A1 (en) * 1994-06-20 1997-05-14 THE UNITED STATES OF AMERICA, reresented by THE SECRETARY, DEPARTMENT OF AGRICULTURE In ovo immunization of avian embryos with oil-emulsion vaccines
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
JP3490536B2 (ja) * 1995-04-21 2004-01-26 株式会社ブリヂストン 空気入りラジアルタイヤ
US5672485A (en) * 1996-08-13 1997-09-30 Regents Of The University Of Minnesota Immortalized cell lines for virus growth

Also Published As

Publication number Publication date
KR20040070250A (ko) 2004-08-06
NZ534070A (en) 2006-01-27
CN1604961A (zh) 2005-04-06
TW200301305A (en) 2003-07-01
US20080102507A1 (en) 2008-05-01
WO2003055988A1 (en) 2003-07-10
TWI267553B (en) 2006-12-01
JP2005514018A (ja) 2005-05-19
AU2002360659B2 (en) 2009-01-08
MXPA04005888A (es) 2004-09-13
CO5590972A2 (es) 2005-12-30
AU2002360659A1 (en) 2003-07-15
PL371381A1 (en) 2005-06-13
HUP0402548A2 (hu) 2005-03-29
CA2471131A1 (en) 2003-07-10
RS55404A (en) 2006-10-27
EP1458851A1 (en) 2004-09-22
AR037908A1 (es) 2004-12-22
HU225995B1 (en) 2008-02-28
EP2157173A1 (en) 2010-02-24
CN100408675C (zh) 2008-08-06
US20090226487A1 (en) 2009-09-10
US20040023358A1 (en) 2004-02-05
HRP20040641A2 (en) 2004-10-31

Similar Documents

Publication Publication Date Title
JP2005270111A (ja) パピローマウイルス様粒子、融合タンパク質並びにそれらの製造方法
BR0114393A (pt) Uso de uma preparação de vìrus envelopado dividido, método para produzir uma formulação de vacina intranasal, uso de uma preparação de vacina de vìrus envolopado dividido, kit para liberação de uma formulação de vacina intranasal, dispositivo de liberação intranasal, e, método para proteger ou tratar um mamìfero susceptìvel a, ou sofrendo de doença causada por vìrus envelopado
BRPI0516953A (pt) partìculas do tipo vìrus compreendendo uma proteìna de fusão da proteìna de revestimento de ap205 e um polipeptìdeo antigênico
BR0309339A (pt) Vìrus vaccinia modificado ankara para a vacinação de neonatos
CN1299288A (zh) 联合疫苗组合物
MA24638A1 (fr) Vaccin
WO2007019247A3 (en) Virus-like particles as vaccines for paramyxovirus
NO20023829L (no) Proteosom influensavaksine
DE60110822D1 (de) Zubereitung zur immunisierung gegen den aids-virus
BR0213941A (pt) Arranjos de antìgeno para o tratamento de doença óssea
DE69033728D1 (de) Impfstoffkonjugat
PT98202A (pt) Processo para a preparacao de uma vacina contra a doenca de lyme, compreendendo uma quantidade dos principais antigenios contra b.burgdorferi
ES2549669T3 (es) Propiedades de coadyuvancia y potenciación inmunitaria de productos naturales de Onchocerca volvulus
ATE152768T1 (de) Zusammengestellte virenpartikeln und ihre verwendung in einem impfstoff gegen eine rotavirenkrankheit
AR004464A1 (es) Un metodo para producir una proteina de capside de papilomavirus
BR0215013A (pt) Biomassa particulada de embrião aviário para a produção de antìgenos de vìrus
Hilleman Personal historical chronicle of six decades of basic and applied research in virology, immunology, and vaccinology
FI95871B (fi) Menetelmä HIV-hiukkasimmunogeenin ja sen vasta-aineen valmistamiseksi
CA2499430A1 (en) Chicken astrovirus type 2
MX9304310A (es) Antigenos en forma de particulas y metodo para su produccion.
ATE517186T1 (de) Chimäre tymovirus-ähnliche partikel
HU0002908D0 (en) Recombinant newcastle disease virus as embryo vaccine
BR0101523A (pt) Pestivìrus, vacina, e, processos para imunizarcontra doença induzida por pestivìrus e parafabricar uma vacina para a proteção de um animalcontra um pestivìrus
WO2002000252A3 (en) Non-human animal models of tolerance to hepatitis c virus immunogenes
RU95104923A (ru) Штамм вируса герпеса кур "42" - деп для изготовления вакцины против болезни марека

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 9A. E 10A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2179 DE 09/10/2012.

B15K Others concerning applications: alteration of classification

Ipc: C12N 7/00 (2006.01), C12N 5/073 (2010.01), A61K 39